Cargando…
Review of Prasugrel for the Secondary Prevention of Atherothrombosis
BACKGROUND: The role of platelets in atherothrombotic disease is well established, and antiplatelet therapy is now recommended for the short and long-term management of patients with acute coronary syndromes (ACS), with and without percutaneous coronary intervention (PCI). The thienopyridine clopido...
Autores principales: | Spinler, Sarah A., Rees, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438003/ https://www.ncbi.nlm.nih.gov/pubmed/19496635 http://dx.doi.org/10.18553/jmcp.2009.15.5.383 |
Ejemplares similares
-
Prasugrel for Secondary Prevention of Thrombotic Stroke
por: Yagita, Yoshiki
Publicado: (2023) -
Cell Stress Proteins in Atherothrombosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2012) -
The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications
por: Drysdale, Amelia, et al.
Publicado: (2023) -
Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010) -
Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis
por: Suades, Rosa, et al.
Publicado: (2022)